U.S. markets close in 2 hours 59 minutes
  • S&P 500

    4,177.64
    +7.22 (+0.17%)
     
  • Dow 30

    34,116.31
    +80.32 (+0.24%)
     
  • Nasdaq

    14,031.73
    -7.03 (-0.05%)
     
  • Russell 2000

    2,254.36
    -2.70 (-0.12%)
     
  • Crude Oil

    63.22
    -0.24 (-0.38%)
     
  • Gold

    1,778.70
    +11.90 (+0.67%)
     
  • Silver

    26.10
    +0.14 (+0.54%)
     
  • EUR/USD

    1.1985
    +0.0009 (+0.07%)
     
  • 10-Yr Bond

    1.5820
    +0.0520 (+3.40%)
     
  • GBP/USD

    1.3828
    +0.0043 (+0.31%)
     
  • USD/JPY

    108.7700
    +0.0540 (+0.05%)
     
  • BTC-USD

    61,847.99
    -1,064.14 (-1.69%)
     
  • CMC Crypto 200

    1,390.70
    -1.01 (-0.07%)
     
  • FTSE 100

    7,019.53
    +36.03 (+0.52%)
     
  • Nikkei 225

    29,683.37
    +40.68 (+0.14%)
     

LAWSUITS FILED AGAINST YY, NERV and OTGLY - Jakubowitz Law Pursues Shareholders Claims

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / January 15, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Joyy Inc. (NASDAQ:YY)

CONTACT JAKUBOWITZ ABOUT YY:
https://claimyourloss.com/securities/joyy-inc-loss-submission-form/?id=12204&from=1

Class Period : April 28, 2016 - November 18, 2020

Lead Plaintiff Deadline : January 19, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) JOYY dramatically overstated its revenues from live streaming sources; (2) The majority of users at any given time were bots; (2) the Company utilized these bots to effect a roundtripping scheme that Manufactured the false appearance of revenues; (3) the Company overstated its cash reserves; (4) the Company's acquisition of Bigo was largely contrived to benefit corporate insiders; and (5) as a result, Defendants' public statements were materially false and/or Misleading at all relevant times.

Minerva Neurosciences, Inc. (NASDAQ:NERV)

CONTACT JAKUBOWITZ ABOUT NERV:
https://claimyourloss.com/securities/minerva-neurosciences-inc-loss-submission-form/?id=12204&from=1

Class Period : May 15, 2017 - November 30, 2020

Lead Plaintiff Deadline : February 8, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the truth about the feedback received from the FDA concerning the "end-of-Phase 2" meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company's plan to use the combination of the Phase 2b and Phase 3 studies would be "highly unlikely" to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to "substantial review issues" because the trials were inadequate and not well-controlled; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

CD Projekt S.A. (OTC PINK:OTGLY)

CONTACT JAKUBOWITZ ABOUT OTGLY:
https://claimyourloss.com/securities/cd-projekt-s-a-loss-submission-form/?id=12204&from=1

Class Period : January 16, 2020 - December 17, 2020

Lead Plaintiff Deadline : February 22, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: Throughout the class period, defendants were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company's business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or Playstation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the Playstation store, and Sony, Microsoft and the Company would be forced to offer full refunds for the game; (3) consequently, the Company would suffer reputational and pecuniary harm; and (4) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/624569/LAWSUITS-FILED-AGAINST-YY-NERV-and-OTGLY--Jakubowitz-Law-Pursues-Shareholders-Claims